CerRx Receives $1.1 Million NIH Grant for Cancer Study - MyHighPlains.com

CerRx, Inc. (CerRx) today [Thursday] announced that it has been awarded a non-diluting National Institute of Health (NIH) grant of $1.1M to support a Phase I study combining its two lead investigational compounds intravenous (IV) fenretinide and IV safingol. These drugs act together to specifically kill cancer cells by increasing certain toxic ‘ceramide’ waxes in cancer cells.

...

C. Patrick Reynolds, M.D., Ph.D., chief scientific officer of CerRx and director at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, said, “The combination of fenretinide plus safingol provides a very exciting and novel approach to selectively attacking cancer cells of many types in adults and children and we are delighted that this imporant clinical trial will be carried out here in Texas.”

Read the full story >>

Related Stories

How Does Your Garden Grow?

As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.

Adopt a Growth Mindset for a Better Life

A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.

Drug Use, Family History Can Lead to Heart Disease in Younger Adults

Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.

Recent Stories

Education

PAs and Telehealth: Increasing Access to Patient Care

The PA profession and telehealth were both created to improve and expand access to patient care. PA Abby Buterbaugh discussed the value that her profession and telehealth has brought to health care.

Health

Food Allergy Awareness, Prevention Ahead of Summer Fun

James Tarbox, M.D., Texas Tech Physicians allergist, discussed food allergies and treatments.

Research

National Academy of Inventors Ranks Texas Tech University System Among Top 100 in Patents for Second Consecutive Year

The TTU System, including the TTUHSC and TTUHSC El Paso, ranked 74th on the NAI list of Top 100 U.S. Universities Granted Utility Patents for 2023.